Stay updated with breaking news from Oene Mark Van. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective lowered by Morgan Stanley from $10.00 to $4.00 in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has an equal weight rating on the biotechnology company’s stock. A number of other analysts have also recently weighed in on […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price decreased by Morgan Stanley from $10.00 to $4.00 in a research note issued to investors on Wednesday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the biotechnology company’s stock. PACB has been the subject of a number of other […]
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) were up 10.1% on Monday . The company traded as high as $2.03 and last traded at $2.02. Approximately 5,116,811 shares traded hands during mid-day trading, a decline of 48% from the average daily volume of 9,845,091 shares. The stock had previously closed […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) shares shot up 10.1% during trading on Monday . The company traded as high as $2.03 and last traded at $2.02. 5,116,811 shares traded hands during mid-day trading, a decline of 48% from the average session volume of 9,845,091 shares. The stock had previously closed […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report)’s share price gapped up prior to trading on Friday . The stock had previously closed at $1.76, but opened at $1.87. Pacific Biosciences of California shares last traded at $1.90, with a volume of 3,423,121 shares trading hands. Analyst Ratings Changes PACB has been the […]